A carregar...

Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer

BACKGROUND: Bladder cancer (BLCA) is a common malignant tumor of urinary system with high morbidity and mortality. In recent years, immunotherapy has played a significant role in the treatment of BLCA. Tumor mutation burden (TMB) has been reported to be a powerful biomarker for predicting tumor prog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Zhang, Zhao, Yu, Yongbo, Zhang, Pengfei, Ma, Guofeng, Zhang, Mingxin, Liang, Ye, Jiao, Wei, Niu, Haitao
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8070296/
https://ncbi.nlm.nih.gov/pubmed/33894748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08229-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!